Malaria Research Products

Malaria is a mosquito-borne infectious disease caused by the bite of female Anopheles mosquitoes, which spread infectious Plasmodium parasites into a host. Traditional malaria symptoms include fever, chills, headaches, muscle aches, and fatigue. Nausea, vomiting, and diarrhoea are also common. Untreated malaria can lead to severe disease, kidney failure, and death. Neurological complications can occur in severe cases, most commonly in young children. Most malaria cases occur during rainy periods in endemic regions. According to the World Health Organization, globally, about 240 million people had malaria, and about 627,000 of them died. Each year, there are more than 200 million new cases of malaria.

A vaccine to prevent malaria is available; however, its variable efficacy underscores the need for new interventions that offer high-level protection against the disease. Malaria is a research priority in India. Scientists are researching improved vaccines and preventive interventions, as well as mosquito control techniques, easy-to-use diagnostics, and improved therapies, as parasites continue to develop resistance to currently available antimalarials. To support the research on malaria, BTL Biotechno Labs Pvt. Ltd. has joined hands with multiple renowned biomedical brands like Arista Biological Inc., East Coast Bio, Abbexa, Quansys Bioscience, and Cusabio to provide a wide range of malarial research products, such as antibodies specific to the plasmodium lactate dehydrogenase enzyme (pLDH), which is produced only in cases of active malaria, monoclonal & polyclonal antibodies, proteins, peptides, recombinant proteins & antibodies, matched pair antibodies, ELISA kits, and rapid test kits to the Indian scientific community at competitive prices with fast delivery and technical support.